Summary

The global drug screening market size was valued at USD 7.3 Billion in 2025. Looking forward, it is estimated that the market to reach USD 12.4 Billion by 2034, exhibiting a CAGR of 5.87% from 2026-2034. North America currently dominates the market, holding a market share of over 51% in 2025. The growth of the North American region is driven by stringent workplace regulations, advanced testing technologies, and increased substance abuse awareness.

Drug Screening Market Analysis:
Major Market Drivers: Increasing demand for drug screening as it is accurate and provides spontaneous results is primarily driving the growth of the market. Furthermore, the rising cases of substance abuse around the world are also propelling the global market.

Key Market Trends: The integration of advanced technologies such as automation, artificial intelligence (AI), and molecular diagnostics with drug screening tests to streamline workflows, reduce human errors, and enhance testing is acting as one of the significant key trends, bolstering the market growth.

Competitive Landscape: Some of the leading drug screening market companies include Abbott Laboratories, Alfa Scientific Designs Inc., Bio-Rad Laboratories Inc., Drägerwerk AG & Co. KGaA, Laboratory Corporation of America Holdings, Lifeloc Technologies Inc., Omega Laboratories Inc., OraSure Technologies Inc., Psychemedics Corporation, Quest Diagnostics Incorporated, Siemens AG, and Thermo Fisher Scientific Inc., among others.

Geographical Trends: According to the report, North America is the largest market for drug screening. The growth of the region can be attributed to the escalating cases of substance abuse, the increasing number of drug dealers, and the rising black marketing of prescribed drugs.

Challenges and Opportunities: The drug screening market faces hurdles related to the development of accurate and reliable tests, overcoming false positives and negatives, and addressing privacy and ethical concerns regarding sample collection and testing procedures. Opportunities lie in the integration of advanced technologies such as AI and machine learning for data analysis and the development of portable and point-of-care testing devices for convenient and rapid screening applications.


Drug Screening Market Trends:
Rise in Drug and Alcohol Consumption
The increasing consumption of drugs is resulting in an increased demand for drug-screening products. For instance, according to the 2023 European Drug Report, approximately 83.4 million adults (29%) in the European Union have reportedly used illicit drugs at least once. Cannabis is the predominant illicit drug consumed in Europe, with an estimated 8% of European adults using it in 2022, based on national surveys. Thus, a high number of the population consumes drugs, which impacts the lives of individuals and is likely to increase demand for drug screening, thereby bolstering the drug screening market’s recent price. Additionally, the rising utilization of drugs and alcohol, along with the need for treatment, is anticipated to drive up the demand for drug screening in hospitals. For instance, as per National statistics published by GOV. UK, in December 2023, between April 2022 and March 2023, around 290,635 adults received support for substance use issues. This is a small rise compared to the previous year, around 289,215. Moreover, the same source stated that the number of adults entering treatment from 2022 to 2023 was approx. 137,749, which is higher than the previous two years’ figures of 130,490 and 133,704. Such a significant rise in the number of people undergoing substance use is anticipated to propel the drug screening market demand.


Government Regulations
Several laws and regulations mandate drug and alcohol testing in various sectors, and the implementation of such laws is augmenting the demand for drug-screening products and devices. For instance, in November 2022, the Federal Motor Carrier Safety Administration (FMCSA) released updates outlining the drug and alcohol testing requirements. These regulations specify the individuals subject to testing, the frequency of testing, and the circumstances triggering testing. Additionally, the regulations safeguard employee privacy by limiting the use and disclosure of sensitive drug and alcohol testing information by employers and service agents. Besides the regulatory framework, government authorities of various nations are also taking initiatives to help severe addicts and individuals suffering from drug abuse, which is further propelling the drug screening market share. For instance, Nasha Mukt Bharat Abhiyaan is a program by the Indian Government that intends to reach out to the masses and spread awareness about substance abuse through various activities like awareness generation programs. Similarly, the government authorities of Canada are also investing in anti-drug strategy projects to help people with addiction come out of substance abuse. For example, the Calgary John Howard Society in Alberta, Canada, focuses on assisting youths aged 13 to 24 who face the risk of school dropout due to drug addiction.


Advancements in Testing Technologies
Ongoing advancements in drug screening technologies, such as rapid testing kits, laboratory-based assays, and point-of-care devices, are further driving the market growth by offering faster, more accurate, and cost-effective screening solutions. Moreover, the continuous improvement of drug screening technologies is resulting in enhanced accuracy and reliability and reduced likelihood of false positives or false negatives, ensuring confidence in test results and minimizing the need for confirmatory testing, thereby streamlining the screening process and reducing costs. For instance, in February 2024, Mobile Health introduced a new rapid drug testing service in New York clinics for employers to screen and hire candidates easily. Similarly, in October 2023, ProciseDx Inc. received de novo FDA clearance for the therapeutic drug monitoring (TDM) tests for adalimumab (Humira and biosimilar Amgevita) and infliximab (Remicade and biosimilars Inflectra and Renflexis). These assays, called Procise ADL and Procise IFX, are used to quantify adalimumab (ADL) and infliximab (IFX) in patients suffering from inflammatory bowel diseases (IBD) who are taking these drugs. Increasing approval of new drug tests and instruments is anticipated to propel the drug screening market revenue in the coming years.


Global Drug Screening Industry Segmentation:
This report provides an analysis of the key trends in each segment of the global drug screening market, along with forecast at the global, regional, and country levels from 2026-2034. The market has been categorized based on product and service, sample type, and end user.


Breakup by Product and Service:
• Equipment
• Immunoassay Analyzers
• Chromatography Instruments
• Breath Analyzers
• Rapid Testing Devices
• Urine Testing Devices
• Oral Fluid Testing Devices
• Consumables
• Assay Kits
• Sample Collection Cups
• Calibrators and Controls
• Others
• Laboratory Services
Rapid testing devices represented the largest segment
The drug screening market report has provided a detailed breakup and analysis of the drug screening market based on the product and service. This includes equipment (immunoassay analyzers, chromatography instruments, and breath analyzers); rapid testing devices (urine testing devices and oral fluid testing devices); consumables (assay kits, sample collection cups, calibrators and controls, and others); and laboratory services. According to the report, rapid testing devices (urine testing devices and oral fluid testing devices) represented the largest segment.

Rapid drug screening test devices are portable, easy-to-use tools designed for quick detection of drugs in various sample types, such as urine, saliva, or blood. These devices offer several benefits, including rapid results within minutes, enabling on-the-spot decision-making in scenarios like workplace testing or roadside screening. Their simplicity allows for minimal training requirements, making them accessible to a wide range of users. Moreover, rapid tests are cost-effective, reducing the need for laboratory analysis and turnaround time. For instance, Dräger, a German company based in Lübeck that makes breathing and protection equipment, gas detection and analysis systems, and non-invasive patient monitoring technologies, introduced a rapid test named DrugTest 5000. In this test, saliva samples can be analyzed immediately for an accurate result on the spot. Furthermore, rapid screening devices play a crucial role in emergencies, aiding in the quick identification of drug intoxication or overdose for prompt medical intervention.


Breakup by Sample Type:
• Urine Samples
• Breath Samples
• Oral Fluid Samples
• Hair Samples
• Others
Urine samples accounted for the largest market share
A detailed breakup and analysis of the drug screening market based on the sample type has also been provided in the report. This includes urine samples, breath samples, oral fluid samples, hair samples, and others. According to the report, urine samples accounted for the largest market share.

As per the drug screening market overview, urine sample drug testing offers several benefits, making it a preferred method over other sample types in many scenarios. Firstly, urine testing is non-invasive and relatively easy to collect, minimizing discomfort and ensuring employee cooperation. Secondly, urine samples can detect a wide range of drugs and their metabolites, providing comprehensive screening capabilities. Thirdly, urine testing is cost-effective and suitable for high-volume testing, making it practical for workplace screening programs. Furthermore, urine testing is capable of detecting recent drug use, making it suitable for detecting impairment in safety-sensitive industries. Lastly, this testing is less susceptible to adulteration or tampering compared to other sample types, ensuring the integrity and reliability of test results.


Breakup by End User:
• Hospitals
• Drug Testing Laboratories
• Workplaces
• Drug Treatment Centers
• Pain Management Centers
• Personal Users
• Criminal Justice System and Law Enforcement Agencies
Workplaces accounted for the largest market share
A detailed breakup and analysis of the drug screening market based on the end user has also been provided in the report. This includes hospitals, drug testing laboratories, workplaces, drug treatment centers, pain management centers, personal users, and criminal justice system and law enforcement agencies. According to the report, workplaces accounted for the largest market share.

Drug screening tests in workplaces are conducted to detect the presence of drugs or alcohol in employees. These tests are typically performed as part of pre-employment screening, random testing, post-accident testing, or reasonable suspicion testing. The aim is to ensure a safe and productive work environment, minimize the risk of accidents and injuries, and deter substance abuse among employees.


Breakup by Region:
• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
North America (the United States and Canada) was the largest market for drug screening
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for drug screening.

Some of the factors driving the North America drug screening market included the growing cases of substance abuse, the increasing number of drug dealers, and the rising black marketing of prescribed drugs. Moreover, drug screening market statistics indicate that the growing substance abuse rates in the region are bolstering the need for drug screening. For instance, in February 2023, according to an article published by the Pennsylvania State University, around 63% of adults aged 18 years and above were reported to alcohol consumption in the United States in 2022. Among these, males (66%) had higher alcohol consumption as compared to females (61%). Thus, the large number of alcohol consumers raises the need for drug-testing products and services and is augmenting the market growth in North America. Moreover, the government authorities of North America are mandating drug screening tests in various sectors, which is further catalyzing the market growth. For instance, in May 2023, the United States Department of Transportation regulated the drug testing program by including oral fluid testing to improve safety and reduce the chances of cheating involved with urine drug tests.


Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global drug screening market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include:

• Abbott Laboratories
• Alfa Scientific Designs Inc.
• Bio-Rad Laboratories Inc.
• Drägerwerk AG & Co. KGaA
• Laboratory Corporation of America Holdings
• Lifeloc Technologies Inc.
• Omega Laboratories Inc.
• OraSure Technologies Inc.
• Psychemedics Corporation
• Quest Diagnostics Incorporated
• Siemens AG
• Thermo Fisher Scientific Inc.

Key Questions Answered in This Report
1. What is drug screening?
2. How big is the drug screening market?
3. What is the expected growth rate of the global drug screening market during 2026-2034?
4. What is the purpose of drug screening?
5. What are the different samples that can be used for drug screening?
6. What are the key factors driving the global drug screening market?
7. What is the leading segment of the global drug screening market based on product and service?
8. What is the leading segment of the global drug screening market based on sample type?
9. What is the leading segment of the global drug screening market based on end user?
10. What are the key regions in the global drug screening market?
11. Who are the key players/companies in the global drug screening market?

ページTOPに戻る

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Drug Screening Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product and Service
6.1 Equipment
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Immunoassay Analyzers
6.1.2.2 Chromatography Instruments
6.1.2.3 Breath Analyzers
6.1.3 Market Forecast
6.2 Rapid Testing Devices
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Urine Testing Devices
6.2.2.2 Oral Fluid Testing Devices
6.2.3 Market Forecast
6.3 Consumables
6.3.1 Market Trends
6.3.2 Key Segments
6.3.2.1 Assay Kits
6.3.2.2 Sample Collection Cups
6.3.2.3 Calibrators and Controls
6.3.2.4 Others
6.3.3 Market Forecast
6.4 Laboratory Services
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Sample Type
7.1 Urine Samples
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Breath Samples
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Oral Fluid Samples
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Hair Samples
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Drug Testing Laboratories
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Workplaces
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Drug Treatment Centers
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Pain Management Centers
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Personal Users
8.6.1 Market Trends
8.6.2 Market Forecast
8.7 Criminal Justice System and Law Enforcement Agencies
8.7.1 Market Trends
8.7.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Alfa Scientific Designs Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Bio-Rad Laboratories Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Drägerwerk AG & Co. KGaA
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Laboratory Corporation of America Holdings
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.6 Lifeloc Technologies Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.7 Omega Laboratories Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 OraSure Technologies Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Psychemedics Corporation
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.10 Quest Diagnostics Incorporated
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.11 Siemens AG
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Thermo Fisher Scientific Inc.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis

ページTOPに戻る

List of Tables/Graphs

List of Figures
Figure 1: Global: Drug Screening Market: Sales Value (in Billion USD), 2020-2025
Figure 2: Global: Drug Screening Market Forecast: Sales Value (in Billion USD), 2026-2034
Figure 3: Global: Drug Screening Market: Breakup by Product and Service (in %), 2025
Figure 4: Global: Drug Screening Market: Breakup by Sample Type (in %), 2025
Figure 5: Global: Drug Screening Market: Breakup by End User (in %), 2025
Figure 6: Global: Drug Screening Market: Breakup by Region (in %), 2025
Figure 7: Global: Drug Screening (Equipment) Market: Sales Value (in Million USD), 2020 & 2025
Figure 8: Global: Drug Screening (Equipment) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 9: Global: Drug Screening (Rapid Testing Devices) Market: Sales Value (in Million USD), 2020 & 2025
Figure 10: Global: Drug Screening (Rapid Testing Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 11: Global: Drug Screening (Consumables) Market: Sales Value (in Million USD), 2020 & 2025
Figure 12: Global: Drug Screening (Consumables) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 13: Global: Drug Screening (Laboratory Services) Market: Sales Value (in Million USD), 2020 & 2025
Figure 14: Global: Drug Screening (Laboratory Services) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 15: Global: Drug Screening (Urine Samples) Market: Sales Value (in Million USD), 2020 & 2025
Figure 16: Global: Drug Screening (Urine Samples) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 17: Global: Drug Screening (Breath Samples) Market: Sales Value (in Million USD), 2020 & 2025
Figure 18: Global: Drug Screening (Breath Samples) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 19: Global: Drug Screening (Oral Fluid Samples) Market: Sales Value (in Million USD), 2020 & 2025
Figure 20: Global: Drug Screening (Oral Fluid Samples) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 21: Global: Drug Screening (Hair Samples) Market: Sales Value (in Million USD), 2020 & 2025
Figure 22: Global: Drug Screening (Hair Samples) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 23: Global: Drug Screening (Other Sample Types) Market: Sales Value (in Million USD), 2020 & 2025
Figure 24: Global: Drug Screening (Other Sample Types) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 25: Global: Drug Screening (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
Figure 26: Global: Drug Screening (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 27: Global: Drug Screening (Drug Testing Laboratories) Market: Sales Value (in Million USD), 2020 & 2025
Figure 28: Global: Drug Screening (Drug Testing Laboratories) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 29: Global: Drug Screening (Workplaces) Market: Sales Value (in Million USD), 2020 & 2025
Figure 30: Global: Drug Screening (Workplaces) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 31: Global: Drug Screening (Drug Treatment Centers) Market: Sales Value (in Million USD), 2020 & 2025
Figure 32: Global: Drug Screening (Drug Treatment Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 33: Global: Drug Screening (Pain Management Centers) Market: Sales Value (in Million USD), 2020 & 2025
Figure 34: Global: Drug Screening (Pain Management Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 35: Global: Drug Screening (Personal Users) Market: Sales Value (in Million USD), 2020 & 2025
Figure 36: Global: Drug Screening (Personal Users) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 37: Global: Drug Screening (Criminal Justice System and Law Enforcement Agencies) Market: Sales Value (in Million USD), 2020 & 2025
Figure 38: Global: Drug Screening (Criminal Justice System and Law Enforcement Agencies) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 39: North America: Drug Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 40: North America: Drug Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 41: United States: Drug Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 42: United States: Drug Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 43: Canada: Drug Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 44: Canada: Drug Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 45: Asia-Pacific: Drug Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 46: Asia-Pacific: Drug Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 47: China: Drug Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 48: China: Drug Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 49: Japan: Drug Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 50: Japan: Drug Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 51: India: Drug Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 52: India: Drug Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 53: South Korea: Drug Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 54: South Korea: Drug Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 55: Australia: Drug Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 56: Australia: Drug Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 57: Indonesia: Drug Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 58: Indonesia: Drug Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 59: Others: Drug Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 60: Others: Drug Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 61: Europe: Drug Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 62: Europe: Drug Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 63: Germany: Drug Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 64: Germany: Drug Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 65: France: Drug Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 66: France: Drug Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 67: United Kingdom: Drug Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 68: United Kingdom: Drug Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 69: Italy: Drug Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 70: Italy: Drug Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 71: Spain: Drug Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 72: Spain: Drug Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 73: Russia: Drug Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 74: Russia: Drug Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 75: Others: Drug Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 76: Others: Drug Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 77: Latin America: Drug Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 78: Latin America: Drug Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 79: Brazil: Drug Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 80: Brazil: Drug Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 81: Mexico: Drug Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 82: Mexico: Drug Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 83: Others: Drug Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 84: Others: Drug Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 85: Middle East and Africa: Drug Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 86: Middle East and Africa: Drug Screening Market: Breakup by Country (in %), 2025
Figure 87: Middle East and Africa: Drug Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 88: Global: Drug Screening Industry: SWOT Analysis
Figure 89: Global: Drug Screening Industry: Value Chain Analysis
Figure 90: Global: Drug Screening Industry: Porter's Five Forces Analysis

List of Tables
Table 1: Global: Drug Screening Market: Key Industry Highlights, 2025 and 2034
Table 2: Global: Drug Screening Market Forecast: Breakup by Product and Service (in Million USD), 2026-2034
Table 3: Global: Drug Screening Market Forecast: Breakup by Sample Type (in Million USD), 2026-2034
Table 4: Global: Drug Screening Market Forecast: Breakup by End User (in Million USD), 2026-2034
Table 5: Global: Drug Screening Market Forecast: Breakup by Region (in Million USD), 2026-2034
Table 6: Global: Drug Screening Market: Competitive Structure
Table 7: Global: Drug Screening Market: Key Players